I just uncovered 2 articles in my pile from the journal
The old mainstay for prevention of stroke in patients with atrial fibrillation, warfarin (or Coumadin) may be further pushed aside by newer options based on the findings of a study published in the journal Stroke this month. Warfarin is a difficult drug because it requires frequent monitoring due to poor predictability of effect.
Mention risk of bleeding with selective serotonin reuptake inhibitor (SSRI) medications and many doctors will look at you quizzically.
An intracerebral hemorrhage (ICH) is one of the most serious problems that humans face.